beclomet easyhaler 100 mikrogram/dosis inhalationspulver
orion corporation - beclometasondipropionat - inhalationspulver - 100 mikrogram/dosis
beclomet easyhaler 200 mikrogram/dosis inhalationspulver
orion corporation - beclometasondipropionat - inhalationspulver - 200 mikrogram/dosis
beclometasondipropionat "paranova" 100 mikrogram/dosis inhalationsspray, opløsning
paranova danmark a/s - beclometasondipropionat - inhalationsspray, opløsning - 100 mikrogram/dosis
beclomet easyhaler 400 mikrogram/dosis inhalationspulver
orion corporation - beclometasondipropionat - inhalationspulver - 400 mikrogram/dosis
beclometasondipropionat carefarm 100 mikrogram/dosis inhalationsspray, opløsning
orifarm a/s - beclometasondipropionat - inhalationsspray, opløsning - 100 mikrogram/dosis
fostair 100+6 mikrog./dosis inhalationsspray, opløsning
2care4 aps - beclometasondipropionat, formoterolfumarat dihydrat - inhalationsspray, opløsning - 100+6 mikrog./dosis
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrat, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
trydonis
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrat, glycopyrronium - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - vedligeholdelsesbehandling hos voksne patienter med moderat til svær kronisk obstruktiv lungesygdom (kol), der ikke er tilstrækkeligt behandlet ved en kombination af et inhaleret binyrebarkhormon og en langtidsvirkende beta2-agonist (for effekter på symptomer kontrol og forebyggelse af eksacerbationer se afsnit 5.
beconase 50 mikrogram/dosis næsespray, suspension
glaxosmithkline pharma a/s - beclometasondipropionatmonohydrat - næsespray, suspension - 50 mikrogram/dosis
beconase 50 mikrogram/dosis næsespray, suspension
2care4 aps - beclometasondipropionatmonohydrat - næsespray, suspension - 50 mikrogram/dosis